4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010012
CHIEF COMMERCIAL OFFICER gave up 984 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 3,352 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Option exercise | +1,611 | 25,167 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Option exercise | +1,741 | 26,908 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Shares withheld for taxes | −473 | $21.77 | $10,297 | 26,435 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Shares withheld for taxes | −511 | $21.77 | $11,124 | 25,924 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Grant or award · Share Option | +39,364 | 39,364 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Grant or award · Restricted Share Unit | +9,828 | 9,828 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Grant or award · Performance Share Unit | +19,657 | 19,657 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Option exercise · Restricted Share Unit | −1,611 | 3,222 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-01 | Option exercise · Restricted Share Unit | −1,741 | 5,221 | D | ||
Loading xslF345X05/form4-04032025_090416.xml…